Intra-tumour heterogeneity: demonstrating the importance of robust tissue validation for use in External Quality Assessment (EQA)

被引：0
|
作者：
Cheetham, M. H. [1 ]
Wolstenholme, N. L. [1 ]
Patton, S. J. [1 ]
机构：
[1] EMQN CIC, Manchester, Lancs, England
来源：
VIRCHOWS ARCHIV | 2024年 / 485卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
PS-19-012
引用
收藏
页码：S131 / S131
页数：1
相关论文
共 16 条
  • [1] Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors – assessment of intra-tumour heterogeneity
    Viktoria Stühler
    Jens Bedke
    BMC Medicine, 14
  • [2] Tumour response in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors - assessment of intra-tumour heterogeneity
    Stuehler, Viktoria
    Bedke, Jens
    BMC MEDICINE, 2016, 14
  • [3] Prospective technical validation and assessment of intra-tumour heterogeneity of a low density array hypoxia gene profile in head and neck squamous cell carcinoma
    Betts, Guy N. J.
    Eustace, Amanda
    Patiar, Shalini
    Valentine, Helen R.
    Irlam, Joely
    Ramachandran, Anassuya
    Merve, Ashirwad
    Homer, Jarrod J.
    Moeller-Levet, Carla
    Buffa, Francesca M.
    Hall, Gillian
    Miller, Crispin J.
    Harris, Adrian L.
    West, Catharine M. L.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (01) : 156 - 165
  • [4] An assessment of intra-tumour staining heterogeneity in diffuse large B-cell lymphoma sub-classification
    Reade, S.
    Byers, R.
    Radford, J.
    Linton, K.
    Hall, J.
    VIRCHOWS ARCHIV, 2014, 465 : S27 - S28
  • [5] Results of the first external quality assessment scheme (EQA) for isolation and analysis of circulating tumour DNA (ctDNA)
    Haselmann, Verena
    Ahmad-Nejad, Parviz
    Geilenkeuser, Wolf J.
    Duda, Angelika
    Gabor, Merle
    Eichner, Romy
    Patton, Simon
    Neumaier, Michael
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2018, 56 (02) : 220 - 228
  • [6] Twenty years of experience with the steroid receptor External Quality Assessment program - the paradigm for tumour biomarker EQA studies (Review)
    Geurts-Moespot, J
    Leake, R
    Benraad, TJ
    Sweep, CGJ
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2000, 17 (01) : 13 - 22
  • [7] Spatial intra-tumour heterogeneity in acquired resistance to targeted therapy complicates the use of PDX models for co-clinical cancer studies
    Wellbrock, Claudia
    EMBO MOLECULAR MEDICINE, 2015, 7 (09) : 1087 - 1089
  • [8] Validation of Artificial Plasma for Pre-analytical External Quality Assessment (EQA) of Circulating Free DNA (cfDNA) Extraction
    Williams, V.
    Cheetham, M.
    Wolstenholme, N.
    Hellio, M.
    Patton, S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2024, 26 (11): : S29 - S29
  • [9] Importance of anti-SARS-CoV-2 assay antigenic composition as revealed by the results of the Belgian external quality assessment (EQA) scheme
    Moerman, Alena
    Vernelen, Kris
    China, Bernard
    Capron, Arnaud
    Van den Bossche, Dorien
    Marien, Joachim
    Arien, Kevin K.
    Van Acker, Jos
    Delforge, Marie-Luce
    Reynders, Marijke
    Boel, An
    Depypere, Melissa
    Van Gasse, Natasja
    Vijgen, Sara
    Brauner, Jonathan
    Dujardin, Barbara
    Padalko, Elizaveta
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2022, 102 (02)
  • [10] A Simple, Robust IMRT Optimization Method for Lung Cancer, Accounting for Tissue Heterogeneity and Intra-Fraction Lung Tumour Motion
    McCann, C.
    Purdie, T. G.
    Rehbinder, H.
    Lundin, A.
    Hope, A. J.
    Bezjak, A.
    Bissonnette, J. -P.
    MEDICAL PHYSICS, 2009, 36 (09) : 4319 - 4319
12